Skip to main content
Clinical Trials/NCT02240550
NCT02240550
Completed
N/A

A Prospective, Randomized, Double-armed, Single-blinded, Comparative Clinical Study to Evaluate the Effectiveness of ProFlor vs. Lichtenstein for Inguinal Hernia Repair

Insightra Medical, Inc.1 site in 1 country50 target enrollmentSeptember 2014
ConditionsInguinal Hernia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Inguinal Hernia
Sponsor
Insightra Medical, Inc.
Enrollment
50
Locations
1
Primary Endpoint
Evaluate the immediate and short-term amount of pain.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This investigation will be a double-armed, randomized (Blinded patients and Blinded examiner) prospective study designed to collect perioperative and postoperative data to compare the QOL of ProFlor vs. Lichtenstein inguinal hernia repair.

Detailed Description

The primary objectives of this study will be to evaluate the immediate and short-term amount of post-operative pain, the quality of life (QOL), as well as return to normal activities (work) for the two procedures. Carolinas Comfort Scale (CCS) and Visual Analogue Score (VAS) assessments will be held at regular intervals to evaluate these objectives. The secondary objective of the study is to identify any short-term study related complications/adverse events. The follow up will be immediately post-operative, post-operative day 1, and 1, 2,and 4 weeks. The first and 4th week's visits are mandatory office visits (if possible). If not available for office visit, a CCS assessment will be mailed or will be conducted via phone. Up to 50 patients may be enrolled for this study (25 per arm). A report may be generated for presentation at an international meeting such as the AHS, EHS, or APHS if decided by the lead investigator.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
December 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Insightra Medical, Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Scheduled to undergo routine inguinal hernia repair
  • Male and Female patients between 18 and 65 years old
  • Competent to give consent
  • Clinically relevant inguinal hernia (classification: EHS P L/M 1/2/3)
  • Defect size at operation is between 5mm and 35mm
  • Diagnosed with unilateral, direct, indirect or mixed inguinal hernia
  • Primary hernia at the operative site

Exclusion Criteria

  • Signs of obvious local or systemic infection
  • Any previous surgery on the hernia operative site
  • Hernia is not in the inguinal area
  • Hernia is not identified as indirect or direct
  • Femoral hernias
  • Known collagen disorder
  • Presenting with unstable angina or NYHA class of IV
  • Known Pregnancy or Nursing women
  • Active drug user
  • Recurrence of a repair by any method

Outcomes

Primary Outcomes

Evaluate the immediate and short-term amount of pain.

Time Frame: 1 month

We will evaluate the immediate and short-term amount of pain using the VAS and Carolinas Comfort Scale (CCS) assessments held at regular intervals.

Compare the time required for return to normal activities (work).

Time Frame: 1 month

We will capture the time required to return to normal activities as indicated by the patient.

Secondary Outcomes

  • Identify any short-term related complication/adverse events associated with the procedures.(1 month)

Study Sites (1)

Loading locations...

Similar Trials